Tissue-Specific Mechanisms of Regulatory T Cells in the CNS during Autoimmune Encephalomyelitis
自身免疫性脑脊髓炎期间中枢神经系统调节性 T 细胞的组织特异性机制
基本信息
- 批准号:10581668
- 负责人:
- 金额:$ 49.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-01 至 2027-02-28
- 项目状态:未结题
- 来源:
- 关键词:AblationAntigen PresentationAntigen-Presenting CellsAntigensAreaAutoimmuneAutoimmune DiseasesAxonBehaviorBenchmarkingCNS autoimmunityCalciumCalcium SignalingCandidate Disease GeneCell SurvivalCell TherapyCell membraneCell physiologyCellsCentral Nervous SystemClinical TrialsClonal ExpansionClone CellsCommunicable DiseasesComplexCrowdingCuesDetectionDevelopmentEnsureEnvironmentEvaluationExperimental Autoimmune EncephalomyelitisFailureFunctional disorderGeneticGoalsHealthcareHomeHomeostasisImageImmuneImmune System DiseasesImmune systemImmunosuppressionInfectionInflammationInterleukin-2Ion ChannelKnowledgeLabelMalignant NeoplasmsMediatingMolecularMonitorMovementMultiple SclerosisMyelinOrganOrgan TransplantationOutcomePathologicPathway interactionsPatternPermeabilityPhasePhysiologicalPiezo 1 ion channelPlayPositioning AttributeProcessProteinsRecoveryRegulatory T-LymphocyteReporterResolutionRoleScanningSignal TransductionSpinal CordSurfaceT-Cell ReceptorTestingTherapeuticTissuesTransgenic MiceVisualizationautoinflammatoryaxon injurybasecalcium indicatorcare burdencell behaviorcell motilitycostexperimental studyfightingfollow-upforkhead proteinimmune imagingimmunological synapseimmunoregulationin vivoinsightlymphoid organmouse modelneuroinflammationpreservationratiometricremyelinationrepairedresponsetargeted treatmenttherapeutic evaluationtherapeutic targettissue repairtwo photon microscopytwo-photon
项目摘要
PROJECT SUMMARY/ABSTRACT
Multiple sclerosis (MS) and other autoimmune diseases constitute a major healthcare burden at a cost of >$125
billion per year. Autoimmune disorders arise from a failure of immunoregulatory networks. Regulatory T (Treg)
cells expressing transcription factor forkhead box protein 3 (Foxp3) are indispensable components of these
networks. Moreover, recent studies from several groups suggest that Treg cells also facilitate tissue repair, in
addition to exerting immunosuppression. During autoimmune diseases, Treg cells are activated in lymphoid
organs and home to non-lymphoid target tissues where they persist in specialized niches to limit inflammation
and facilitate tissue repair. Our overall goal is to determine how these Treg cell niches operate in the central
nervous system (CNS) to ameliorate autoimmune neuroinflammation at cellular and molecular levels. Direct
visualization of cell behavior often leads to surprises, new hypotheses, and follow-up experiments contributing to
a better understanding of the mammalian immune system, and how autoimmunity and infectious diseases can
be effectively treated. Building on our expertise in two-photon (2-P) imaging at the cellular level, and Ca2+
signaling at the molecular level, we will use the experimental autoimmune encephalomyelitis (EAE) mouse model
of MS to: 1) elucidate the local cues that drive survival, functional organization in niches, and motility behaviors
of Treg cells in the spinal cord; 2) investigate how Treg cells selectively target processes that incite
neuroinflammation. Our experimental approach includes evaluation of the Piezo1 channels as promising
therapeutic targets to selectively expand Treg cells, an ideal strategy to curb ongoing autoinflammatory
responses while preserving the immune system’s ability to fight new infections. Although this proposal is targeted
specifically to MS, in a broader context our project will provide fundamental insights into how Treg cells fine-tune
tissue inflammation so that better Treg-modifying therapies can be developed for autoimmune disorders, organ
transplantation, cancer, and infectious diseases.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shivashankar Othy其他文献
Shivashankar Othy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shivashankar Othy', 18)}}的其他基金
Tissue-Specific Mechanisms of Regulatory T Cells in the CNS during Autoimmune Encephalomyelitis
自身免疫性脑脊髓炎期间中枢神经系统调节性 T 细胞的组织特异性机制
- 批准号:
10420232 - 财政年份:2022
- 资助金额:
$ 49.69万 - 项目类别:
相似海外基金
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞 - 补充
- 批准号:
10836880 - 财政年份:2023
- 资助金额:
$ 49.69万 - 项目类别:
Targeting MAL2-mediated endocytosis to enhance tumor cell antigen presentation
靶向 MAL2 介导的内吞作用以增强肿瘤细胞抗原呈递
- 批准号:
10734324 - 财政年份:2023
- 资助金额:
$ 49.69万 - 项目类别:
Antigen presentation to the adaptive immune system in the choroid contributes to ocular autoimmune disease
脉络膜中的适应性免疫系统的抗原呈递导致眼部自身免疫性疾病
- 批准号:
10740465 - 财政年份:2023
- 资助金额:
$ 49.69万 - 项目类别:
Investigation of Target Protein Degradation and Its Effect on Enhancing Cancer-Specific Antigen Presentation by Quantitative Mass Spectrometry
通过定量质谱研究靶蛋白降解及其对增强癌症特异性抗原呈递的影响
- 批准号:
23K04971 - 财政年份:2023
- 资助金额:
$ 49.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Promoting cancer cells' antigen presentation for serving as better targets for T cell immunotherapy
促进癌细胞的抗原呈递,作为 T 细胞免疫治疗的更好靶点
- 批准号:
2885451 - 财政年份:2023
- 资助金额:
$ 49.69万 - 项目类别:
Studentship
Targeting immunoproteasome-mediated antigen presentation in colorectal cancer immunotherapy
结直肠癌免疫治疗中靶向免疫蛋白酶体介导的抗原呈递
- 批准号:
10385926 - 财政年份:2022
- 资助金额:
$ 49.69万 - 项目类别:
Lipid Antigen Presentation as a Driver of T2D Inflammation
脂质抗原呈递作为 T2D 炎症的驱动因素
- 批准号:
10509043 - 财政年份:2022
- 资助金额:
$ 49.69万 - 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
- 批准号:
10704008 - 财政年份:2022
- 资助金额:
$ 49.69万 - 项目类别:
Sex Differences in lipid antigen presentation, impact of lipid antigen presentation on peripheral lipid metabolism
脂质抗原呈递的性别差异,脂质抗原呈递对外周脂质代谢的影响
- 批准号:
10818273 - 财政年份:2022
- 资助金额:
$ 49.69万 - 项目类别:
Enhancing antigen presentation in triple negative breast cancers through CD40 agonist, Flt3 ligand, and anthracycline chemotherapy
通过 CD40 激动剂、Flt3 配体和蒽环类化疗增强三阴性乳腺癌的抗原呈递
- 批准号:
10349397 - 财政年份:2022
- 资助金额:
$ 49.69万 - 项目类别: